The first Inovio Pharmaceuticals trade was made in Q4 2016.
Since then Cathie Wood bought shares nine more times and sold shares on four occasions. The investor completely sold their stake between Q1 2020 and Q3 2020.
Avg closing price
Price range
Sold -64.3 Thousand shares
Q3 2020
Avg closing price
$208.52
Price range
$114.84
-
$324.60
Sold 52.9% shares (-72.2 Thousand shares)
Q2 2020
Avg closing price
$160.58
Price range
$85.68
-
$380.28
Sold 64.3% shares (-246 Thousand shares)
Q1 2020
Avg closing price
$61.65
Price range
$35.76
-
$169.08
Increased shares by 56.5% (+138 Thousand shares)
Q4 2019
Avg closing price
$30.09
Price range
$23.64
-
$44.64
Increased shares by 55.4% (+87 Thousand shares)
Q1 2019
Avg closing price
$50.40
Price range
$40.08
-
$61.20
Sold 1.6% shares (-2.62 Thousand shares)
Q4 2018
Avg closing price
$60.75
Price range
$46.68
-
$73.32
Increased shares by 60.5% (+60.2 Thousand shares)
Q3 2018
Avg closing price
$55.69
Price range
$47.04
-
$66.96
Increased shares by 79.8% (+44.2 Thousand shares)
Q2 2018
Avg closing price
$55.16
Price range
$46.56
-
$61.92
Increased shares by 132.1% (+31.5 Thousand shares)
Q1 2018
Avg closing price
$54.12
Price range
$48.60
-
$68.28
Increased shares by 99.7% (+11.9 Thousand shares)
Q4 2017
Avg closing price
$61.98
Price range
$49.56
-
$80.16
Increased shares by 117.6% (+6.46 Thousand shares)
Q3 2017
Avg closing price
$74.41
Price range
$64.32
-
$96.72
Increased shares by 79.2% (+2.43 Thousand shares)
Q2 2017